Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07239661Not ApplicableRecruiting

Electroacupuncture Combined With PD-1 Inhibitor for ECOG2 Advanced NSCLC

Role: lead

NCT06548711Not ApplicableRecruiting

Effect of Transcutaneous Acupoint Electrical Stimulation (TAES) on Postoperative Cough in Lung Cancer

Role: lead

NCT07086300Not ApplicableRecruiting

Electroacupuncture Combined With PD-1 Inhibitor for Elderly Patients With Advanced NSCLC

Role: lead

NCT07034326Phase 2Recruiting

Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer

Role: lead

All 4 trials loaded